Furthermore, apigenin inhibits cancer progression, targeting phosphorylated PI3K, Akt, extracelluar signal-regulated kinases 1/2 (ERK 1/2), and forkhead box class O (FoxO) in the dorsolateral prostate of TRAMP mice [117,125]. The gene discussed is AKT1; the disease is cancer.